关于先锋

Company Profile

Warmly congratulate Pioneer Pharmaceuticals on being awarded the most valuable investment enterprise in China's pharmaceutical industry


Release time:

2020-09-01

The 2020 (37th) National Pharmaceutical Industry Information Annual Conference will be held in Zhuhai, China on August 29, 2020

The 2020 (37th) National Pharmaceutical Industry Information Annual Conference will be held in Zhuhai, China on August 29, 2020

The information annual conference, which enjoys the reputation of "the wind vane of the pharmaceutical industry", closely focuses on the current policy of current affairs, the direction of research and development, marketing strategies and hot spots of investment and financing mergers and acquisitions. The list of "Top 100 Enterprises in China's Pharmaceutical Industry", "Best Industrial Enterprise in China's Pharmaceutical R&D Products", "China's Pharmaceutical Enterprise with the Most Investment Value", and "China's Pharmaceutical Industry with the Most Growth Potential" issued at previous annual conferences, objectively Fairly select the backbone of the industry's development.

Anhui Pioneer Pharmaceutical Co., Ltd. was rated as "the most valuable enterprise for investment" in this meeting. Under the leadership of the board of directors and the core team, the company adheres to the development strategy of "combining innovation and imitation, innovation-driven", actively develops high-end generic drugs, Research and development of innovative drugs, the development of improved new drugs with independent intellectual property rights, and the layout of new preparations. To benefit mankind, the company is committed to the continuous innovation of Chinese people's health, takes quality, brand and character as the company's basic concept, and is committed to becoming a comprehensive pharmaceutical with strong competitiveness integrating R&D, production, production, service and sales. enterprise.

Back →